SPRC Scisparc: neurothera Labs announces initiation of phase iib clinical trial at hannover Medical school in Germany for innovative treatme

SPRC Scisparc: neurothera Labs announces initiation of phase iib clinical trial at hannover Medical school in Germany for innovative treatment of tourette syndrome